Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Allergy and Immunology · Chronic Spontaneous Urticaria

Will My Chronic Spontaneous Urticaria Ever Go Away?

At a Glance

Chronic spontaneous urticaria often improves and may eventually go into remission: studies estimate about 17%–22% remit within one year, 45%–59% by five years, and roughly 73% over 20 years. These are population estimates and cannot predict an individual’s timeline.

For many people, chronic spontaneous urticaria (CSU) is not a lifelong condition. The condition often improves over time, with many individuals eventually achieving full remission [1][2]. However, because the disease course is highly unpredictable, it is impossible to know exactly how long it will last for any one person [3]. The primary goal of care is not to wait for a guaranteed cure, but to safely control your symptoms so you can live a normal, comfortable life while the condition runs its course [3].


Urgent Safety Warning: When Swelling is an Emergency
While CSU commonly causes hives and angioedema (swelling beneath the skin, often on the lips or face), certain types of swelling require immediate medical attention. If you develop swelling of the tongue or throat, trouble breathing or swallowing, voice changes, or faintness, seek emergency care immediately. If you have been prescribed an epinephrine auto-injector for emergencies, follow your emergency action plan.


Spontaneous Remission Timelines

Because studies use different patient groups and different definitions of “remission,” there is no single, universally agreed-upon timeline. However, multiple studies provide a broad picture of how often CSU naturally resolves:

  • 1 Year: Research estimates that roughly 17% to 22% of patients will experience remission within the first year of their diagnosis [1][2].
  • 2 Years: In a large study tracking medical codes, about 33% (one-third) of patients saw their condition resolve within two years [2].
  • 5 Years: By the five-year mark, studies show that roughly 45% to 59% of patients have entered remission [2][4]. One prospective study tracking participants aged 12 and older found that nearly 60% had achieved a strict definition of remission—being completely free of symptoms and medication for at least 6 months [4].
  • Long-Term: A major review estimated that over a 20-year period, approximately 73% of cases naturally resolve, though some individuals do require long-term management [1].

What these numbers mean for you: These percentages are population-level estimates, not a forecast for your personal journey. Studies vary widely based on who was included and how remission was measured. While it is reassuring that a large percentage of people eventually recover, remission can be delayed, and relapses can occur.

Some factors are statistically associated with a longer or more persistent course of CSU. These include having a longer duration of the disease, severe disease activity when diagnosed, older age at onset, being female, having co-existing thyroid disease (like hypothyroidism), or experiencing a combination of CSU and inducible urticaria (hives triggered consistently by physical factors like cold or pressure) [4][5]. Some people also find that NSAIDs (like ibuprofen) temporarily worsen their hives, though this does not necessarily mean the disease will last longer [5]. These factors are merely associations and cannot predict your individual timeline. (Note: Never stop taking medically prescribed aspirin without consulting your doctor).

What Does “Spontaneous” Mean?

Having “spontaneous” urticaria means there is no consistent, reproducible external cause for the hives [6]. It does not mean you are imagining things if you notice that stress, viral infections, or tight clothing seem to make your hives worse. Many people have CSU that is aggravated by these factors, or they have a mix of spontaneous hives and inducible hives.

The Goal of Treatment: Preventive Symptom Control

Because CSU can last for years, treatments are designed to provide prophylactic (preventive) symptom control [3]. The goal is to completely suppress the hives and intense itching so that you can maintain an excellent quality of life [3][7].

When you are on effective treatment and have zero symptoms, you have achieved “symptom control.” This is an important success, but it is not the same as clinical remission [6]. Clinical remission only occurs when you can maintain that symptom-free state after safely stepping down and stopping all medications for at least 6 months [6].

Standard treatments usually start with non-drowsy antihistamines, which may be increased to higher doses under a doctor’s guidance [8]. If those do not work, doctors may prescribe biologics (targeted injected medications like omalizumab) [9][10]. Immunosuppressants (medications that broadly reduce immune system activity, like cyclosporine) are generally reserved as a specialist option for persistent, difficult-to-control CSU [10]. None of these treatments cure the underlying disease; they manage the symptoms safely while the disease takes its natural course [11].

Stepping Down Treatment Safely

Because CSU does eventually resolve in many cases, doctors will monitor you to see if you still need your medication [3]. Once your symptoms have been completely absent for a sustained period, your doctor may suggest a supervised “step-down” approach [12].

This might involve gradually lowering an antihistamine dose or carefully extending the time between biologic injections [12][13]. There is no single validated stopping schedule, and any reduction depends heavily on your specific medication and medical history [3].

Never skip, space out, or stop your medications on your own. If you deliberately stop your medication and your hives return, you risk an unnecessary flare-up. Always work with your clinician to create a safe, supervised plan for stepping down, including an agreed-upon strategy for what to do if symptoms return [13].

Common questions in this guide

What is the remission rate for chronic spontaneous urticaria?
Studies estimate that about 17% to 22% of people with chronic spontaneous urticaria reach remission within one year, about one-third by two years, and roughly 45% to 59% by five years. One long-term review estimated that about 73% of cases naturally resolve over 20 years. These figures vary by study and do not predict one person’s course.
How long does chronic spontaneous urticaria usually last?
CSU has no single predictable duration: it may resolve within a year for some people, while others have symptoms for several years or longer. Studies show that remission becomes more common over time, but relapse can occur and population estimates cannot forecast an individual timeline.
Does being symptom-free on CSU medication mean I am in remission?
Not necessarily. Complete symptom control while taking medication means treatment is working, whereas clinical remission generally means staying symptom-free after medicines are safely reduced and stopped for at least six months. A clinician should decide whether and how to test for this.
What makes CSU more likely to last longer?
Longer disease duration, severe symptoms at diagnosis, older age when CSU began, female sex, coexisting thyroid disease, and both spontaneous and inducible urticaria are associated with a more persistent course. These are statistical associations, not reliable predictions for an individual.
Can I stop or reduce my CSU medication when my hives are gone?
Do not skip, space out, or stop CSU treatment on your own. After symptoms have been fully absent for a sustained period, your clinician may use a supervised step-down plan, but there is no single stopping schedule and symptoms can return.
When is swelling from CSU an emergency?
Seek emergency care for swelling of the tongue or throat, trouble breathing or swallowing, voice changes, or faintness. If you have an epinephrine auto-injector and an emergency action plan, follow that plan.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on chronic urticaria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If my symptoms have been completely controlled on my current medication for a long time, what is our specific, supervised plan to test if I can safely step down?
  2. 2.How often should we use validated tools like the Urticaria Control Test (UCT) or UAS7 (a 7-day symptom tracking diary) to assess my disease activity?
  3. 3.Do I have any factors, such as inducible urticaria or thyroid disease, that might suggest my CSU will follow a longer course?
  4. 4.What is our agreed-upon action plan if my hives or swelling return during a medication step-down?

References

References (13)
  1. 1

    Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review.

    Balp MM, Halliday AC, Severin T, et al.

    Dermatology and therapy 2022; (12(1)):15-27 doi:10.1007/s13555-021-00641-6.

    PMID: 34807372
  2. 2

    Clinical Course of Chronic Spontaneous Urticaria in the Korean Adult Population.

    Kim YS, Park SH, Han K, et al.

    Allergy, asthma & immunology research 2018; (10(1)):83-87 doi:10.4168/aair.2018.10.1.83.

    PMID: 29178681
  3. 3

    Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don't Know.

    Terhorst-Molawi D, Fox L, Siebenhaar F, et al.

    American journal of clinical dermatology 2023; (24(3)):397-404 doi:10.1007/s40257-023-00761-z.

    PMID: 36810982
  4. 4

    Prospective analysis of clinical evolution in chronic urticaria: Persistence, remission, recurrence, and pruritus alone.

    Sánchez J, Álvarez L, Cardona R

    The World Allergy Organization journal 2022; (15(10)):100705 doi:10.1016/j.waojou.2022.100705.

    PMID: 36267098
  5. 5

    Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria.

    Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2017; (31(6)):964-971 doi:10.1111/jdv.14221.

    PMID: 28299827
  6. 6

    Chronic spontaneous urticaria remission definition and therapy stepping down: World Allergy Organization position paper.

    Sánchez J, Pite H, Gómez RM, et al.

    The Journal of allergy and clinical immunology 2025; (155(3)):1050-1056.e2 doi:10.1016/j.jaci.2024.11.039.

    PMID: 39732405
  7. 7

    The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update.

    Maurer M, Zuberbier T, Metz M

    Handbook of experimental pharmacology 2022; (268()):117-133 doi:10.1007/164_2021_506.

    PMID: 34247278
  8. 8

    Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.

    Vestergaard C, Toubi E, Maurer M, et al.

    European journal of dermatology : EJD 2017; (27(1)):10-19 doi:10.1684/ejd.2016.2905.

    PMID: 27882879
  9. 9

    Chronic Spontaneous Urticaria: A Review.

    Kolkhir P, Bonnekoh H, Metz M, Maurer M

    JAMA 2024; (332(17)):1464-1477 doi:10.1001/jama.2024.15568.

    PMID: 39325444
  10. 10

    Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know.

    Kocatürk E, Chu DK, Türk M, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(9)):2252-2269 doi:10.1016/j.jaip.2025.07.021.

    PMID: 40815254
  11. 11

    The future of targeted therapy in chronic spontaneous urticaria.

    Min TK, Saini SS

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2024; (133(4)):367-373 doi:10.1016/j.anai.2024.05.020.

    PMID: 38885835
  12. 12

    Remission of chronic urticaria in patients treated with omalizumab.

    Cvenkel K, Bizjak M, Šelb J, Košnik M

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2024; (33(2)):59-61.

    PMID: 38741391
  13. 13

    Analysis of clinical factors as possible predictors of response to omalizumab and relapse after treatment discontinuation in chronic spontaneous urticaria.

    Foti C, Romita P, Ambrogio F, et al.

    Dermatologic therapy 2022; (35(2)):e15248 doi:10.1111/dth.15248.

    PMID: 34877757

This page is for informational purposes only and does not constitute medical advice. Ask your clinician before changing CSU medication, and seek emergency care for tongue or throat swelling or breathing trouble.